
Text extracted from the exhibit documents filed with the FCC. Open a document above to read the original.
A12726001Rev A Medtronic Confidential PtMan_mdvtldct A12726001_fc.fm 8/10/05 12:08 pm UC200500780 EN Market release 3 x 8 inches (76 mm x 203 mm) MEDTRONIC CARELINK ® MONITOR Model 2490C Patient Manual Caution:Federal Law (USA) restricts this device to sale by or on the order of a physician. A12726001Rev A Medtronic Confidential PtMan_mdvtldct A12726001_fc.fm 8/10/05 12:08 pm UC200500780 EN Market release 3 x 8 inches (76 mm x 203 mm) Explanation of symbols on the device The following are trademarks of Medtronic: Medtronic and Medtronic CareLink Medical equipment with respect to electric shock, fire, and mechanical hazards, only in accordance with UL60601-1, and CAN/CSA C22.2 no. 601.1 Type B equipment Wireless communication enabled Caution:Consult accompanying documents Class II medical equipment Direct current Do not dispose of this product in the unsorted municipal waste stream. Dispose of this product according to local regulations. See http://recycling.medtronic.com for instructions on proper disposal of this product. Caution:Federal Law (USA) restricts this device to sale by or on the order of a physician Serial number Temperature limitations 3 A12726001Rev A Medtronic Confidential PatntR05 A12726001ATOC.fm 8/10/05 12:08 pm EN Market release 3 x 8 inches (76 mm x 203 mm) Contents Introduction5 About your monitor5 Warnings7 Precautions7 Choosing a place to set up your monitor8 Setting up your monitor9 Sending information with your monitor13 Green status lights18 Orange status lights19 Traveling with your monitor21 Monitor care22 Monitor specifications22 A12726001Rev A Medtronic Confidential PatntR05 A12726001ATOC.fm 8/10/05 12:08 pm EN Market release 3 x 8 inches (76 mm x 203 mm) 5 A12726001Rev A Medtronic Confidential PatntR05 A12726001_ch.fm 8/10/05 12:08 pm EN Market release 3 x 8 inches (76 mm x 203 mm) Introduction This manual is intended to help you use the Medtronic CareLink Monitor Model 2490C. If you have any questions that are not answered by this manual, or if you have any problems with the monitor, talk to your doctor. Your doctor knows your medical history and can give you the help you need. About your monitor The Medtronic CareLink Monitor Model 2490C is designed to automatically gather information from your implanted heart device. This automatic wireless communication between your heart device and the monitor takes place at times scheduled by your doctor or clinic. Sending heart device information to your clinic using wireless technology does not require you to interact with your monitor. Clinics typically schedule this automatic process to occur while you sleep. The gathered heart device information is sent over a telephone line to your clinic using a toll-free number. The monitor must always be plugged into a telephone wall jack and a power outlet for this reason. 6 A12726001Rev A Medtronic Confidential PatntR05 A12726001_ch.fm 8/10/05 12:08 pm EN Market release 3 x 8 inches (76 mm x 203 mm) The monitor will also send wireless heart device alerts to your clinic automatically. The information sent to your clinic helps your doctor manage your care. Your phone will be busy while the monitor is sending information. For more information, see “Sending information with your monitor” on page 13. The monitor is intended specifically for your use only. It will not work with other implanted devices and should be used only by you as directed by your doctor. Sending information at the request of your doctor or clinic You will sometimes need to send information at times other than those previously scheduled by your doctor or clinic. These times are: • when completing first-time setup, to allow automatic wireless communication between your monitor and your heart device • at the request of your doctor or clinic See, “Sending information with your monitor” on page 13. 7 A12726001Rev A Medtronic Confidential PatntR05 A12726001_ch.fm 8/10/05 12:08 pm EN Market release 3 x 8 inches (76 mm x 203 mm) Warnings Wa r n i n g :If you are feeling ill and you think you might need to go to the hospital, seek medical attention immediately. If there is an emergency, call 911. If your doctor has provided other instructions, follow them. Do not use the monitor to send your heart device information to your doctor unless you have already contacted your doctor and your doctor has requested that you use the monitor. Wa r n i n g :To ensure the safe operation of your implanted device, use the monitor only as described in this manual and at the times prescribed by your doctor. Wa r n i n g :Do not use the monitor if the monitor does not operate as described in “Sending information with your monitor” on page 13. If you need further assistance, contact your clinic. Precautions • Use only the supplied power cord with this monitor. • Always leave the monitor plugged into a working power outlet and a telephone wall jack. 8 A12726001Rev A Medtronic Confidential PatntR05 A12726001_ch.fm 8/10/05 12:08 pm EN Market release 3 x 8 inches (76 mm x 203 mm) • Do not use a mobile phone while using the monitor. • If possible, avoid using the telephone while using the monitor. Your phone line will be “busy” while the monitor is sending data. Note: In the case of an emergency, you can use your phone to call for help. If you have an emergency while using the monitor, press the Start/ Stop button to stop the monitor and to ensure your phone line is avai lable. • Do not get your monitor wet. Liquids can damage the monitor. If you get your monitor wet, contact your clinic for instructions. Choosing a place to set up your monitor Choose a place to set up your monitor. Follow these recommendations for choosing the right spot: • Place the monitor within ten feet (three meters) of where you sleep, preferably on a night stand or a table. • Place the monitor within reach of a telephone wall jack. 9 A12726001Rev A Medtronic Confidential PatntR05 A12726001_ch.fm 8/10/05 12:08 pm EN Market release 3 x 8 inches (76 mm x 203 mm) • Place…
Text truncated - open the document above for the full version.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4085 Howard Rd Dayton, MD 21936 TRP Inc. September 27, 2005 FCC Laboratory 7435 Oakland Mills Rd Columbia, MD 21036 Gentlemen: Submitted herewith is a request for certification of a Medical Implant Communications system Home Monitoring transmitter, FCC ID:LF5MICSW, that is part of a Medical Implant Communications System. Due to small size of the unit, space limitations on the bottom label, and numerous regulatory label requirements, it is requested that permission be given to locating the Part 2, Part 95 and Part 15 warning statements in the instruction manual. The FCC ID will appear on a label on the equipment. If you have any questions, please call Phillip Inglis at 410 531 3439 or contact via email at [email protected]. It is also requested that you forward copies of any correspondence and authorization documents to the email address specified above. Sincerely, Phillip Inglis Consultant
September 27, 2005 VIA ELECTRONIC FILIING Equipment Authorization Branch Federal Communications Commission Columbia, MD 21046 Re: Medtronic, Inc. Request For Confidentiality FCC ID No.:LF5MICSW Ladies and Gentlemen: Medtronic, Inc. (“Medtronic”) requests that the information contained in the items enumerated below pertaining to the above-referenced application be withheld from public disclosure in accordance with Section 0.459 of the Commission’s Rules, 47 C.F.R. § 0.459 (2001), following grant of the application. In support of this request, Medtronic submits the following: (1) identification of the specific information for which confidential treatment is sought: Schematics Parts List Block Diagram Operational description Internal Photographs The materials set forth in these exhibits, which are segregated from the non- confidential exhibits of the application, are those for which confidentiality is sought. (2) identification of the Commission proceeding in which the information was submitted or a description of the circumstances giving rise to the submission: The proceeding is that involving the certification of FCC ID No.: LF5MICSW. (3) explanation of the degree to which the information is commercial or financial, or contains a trade secret or is privileged: This information is embodied in circuit diagrams, detailed explanations, parts lists, a block diagram and internal photographs of a device designed for patients under the care of a medical professional. As such, this material is treated as highly confidential business information and information that could convey trade secrets pertaining to manufacturing and design techniques. Equipment Authorization Branch September 27, 2005 Page 2 (4) explanation of the degree to which the information concerns a service that is subject to competition: The information for which confidentiality is sought is employed in the design and manufacture of medical implant device systems that are offered on a highly competitive basis. Customers for this equipment have a variety of competing sources of supply from both domestic and foreign suppliers. (5) explanation of how disclosure of the information could result in substantial competitive harm: Disclosure would, in effect, give away the fruits of the labors of Medtronic’s engineering personnel, who have designed the equipment and the manufacturing processes. Disclosure would also offer competitors additional unwarranted insight into the state of product development thereby allowing such competitors an advantage that would not be available to Medtronic. (6) identification of any measures taken by the submitting party to prevent unauthorized disclosure: The information for which confidential treatment is sought is kept confidential by Medtronic and not made available to third parties except pursuant to arrangements designed to prevent public disclosure. (7) identification of whether the information is available to the public and the extent of any previous disclosure of the information to third parties: To the knowledge of those preparing this application, the information has not been disclosed publicly heretofore. The protection sought is narrowly drawn and pertains to certain specific implementations of the technology incorporated into the device for which certification is sought.. (8) justification of the period during which the submitting party asserts that material should not be available for public disclosure: This material should not be disclosed for at least ten years. While improvements in design are likely to be made during this period, disclosure of the design information would lead to insights into both designs and manufacturing techniques and could have an adverse competitive effect for many years to come. This application contains information that will be used in future applications for similar devices. Moreover, the communications aspects of this device are employed in the transmission of highly private medical information to the device. Disclosure of the information for which confidentiality is sought could jeopardize the protection of such personal private medical information generated for the benefit of patients into whom a device has been implanted. As such, it is important that information pertaining to the design and Equipment Authorization Branch September 27, 2005 Page 3 operation of this device not be made available to unauthorized persons who might attempt to use knowledge of the design to compromise the applications for which the equipment will be employed. (9) any other information that the party seeking confidential treatment believes may be useful in assessing whether its request for confidentiality should be granted: See item 8 above. Note that the equipment for which approval is being sought will be employed in applications that inherently carry a premium on security. Respectfully, Phillip Inglis Consultant for Medtronic, Inc.
Dear Mr. Hardt, In your last response dated September 5, 2008, you stated that Medtronic must reply within 5 days (later extended to 9/15/2008) with a more sufficient justification than previously provided in order to continue to maintain confidential treatment for interior photos for FCC ID: LF5MICSW. You also stated that failure to provide a more sufficient justification within the 5 days would result in the following action: “we will remove the confidentiality status by our own motion”. I must admit that I am puzzled by the current above statements for an application that was filed by an authorized agent of the FCC (PCTest TCB) and accepted by the Commission on September 29, 2005. At the time of the above filing, Medtronic made their request for confidential treatment based on a Confidentiality Request Letter that is a permanent part of record for the filing that addressed each point in Section 0.459 (a) and (b) of the Commission’s rules. That justification apparently was acceptable until recently when the application became subject to further review which resulted in your initial correspondence on June 23.2008. In that correspondence you stated Medtronic’s initial letter was not sufficient justification for granting confidential treatment of the interior photos and asked for additional justification. As a result of your initial correspondence, Medtronic in an effort to fulfill your request had the TCB file a brief additional justification for the internal photos as follows; “The EUT uses a proprietary antenna design. Because the EUT is never sold to the general public, but is loaned to a patient, and then recovered by the applicant when the patient no longer requires the device, and the patient is instructed to never open this medical device while using it, the applicant believes its antenna design will not be seen by the patient. Based on this, and in order maintain its competitive advantage, the applicant desires that internal photos of this new antenna design be granted permanent confidential treatment.” On July 28, 2008 you responded with the following; “Upon reading your response (see below), we fail to see the justification for maintaining these internal photos as confidential exhibits.” It appears from your statement that your opinion is based on the fact that the product is used by patients under a loan basis and then returned to Medtronic. You assume that during this time period patients could get access to the internal assemblies even though warned by Medtronic not to do so. I would posit that making such information available via the FCC website where millions of people from all walks of life including competitors of Medtronic cannot be compared with the incidental viewing of the internal apparatus by a curious patient that is using a functional unit to provide valuable therapeutic information to his physician. In any event, I have not been able to find any requirement in the Commission’s confidentiality rules that require a 100% guarantee that individual members of the public (patient in Medtronic’s case) cannot get access to information which has been granted confidential treatment by the Commission. It should be noted that the Commission has granted confidential treatment of internal photos for various products that are controlled by the applicant but released to specific communities that use the products. For example, FCCID:RIASJMRFANT is one such product and another is FCCID: QRIICSPGH. At this time Medtronic maintains that confidential treatment of the internal photos for FCCID:LF5MICSW is warranted under the guidelines in place at the time of filing of the application which appear to be still applicable based on similar request by other applicants for products authorized to be used for medical purposes. If the above is still deemed insufficient justification, consider this as a request to meet with appropriate FCC personnel either at the Lab or in DC to further clarify the Commissions confidentiality position relative to medical equipment that is necessarily released after manufacture to individuals that will use it for medical therapeutic purposes. Sincerely, Phillip Inglis Consultant to Medtronic
MEDTRONIC FCC ID: LF5MICSW EUT Photographs © 2005 PCTEST Lab. Medtronic Cure Link Monitor Model: 2490C MEDTRONIC FCC ID: LF5MICSW EUT Photographs © 2005 PCTEST Lab. Medtronic Cure Link Monitor Model: 2490C MEDTRONIC FCC ID: LF5MICSW EUT Photographs © 2005 PCTEST Lab. Medtronic Cure Link Monitor Model: 2490C MEDTRONIC FCC ID: LF5MICSW EUT Photographs © 2005 PCTEST Lab. Medtronic Cure Link Monitor Model: 2490C MEDTRONIC FCC ID: LF5MICSW EUT Photographs © 2005 PCTEST Lab. Medtronic Cure Link Monitor Model: 2490C
FCC ID and IC label with location FCC ID:LF5MICSW IC:3408D-MICSW Trade Name: Medtronic Model No. 2490C or 2490W The label is located on the bottom of the unit.
© 2005 PCTEST Engineering Lab., Inc. PCTEST Engineering Laboratory, Inc. 6660-B Dobbin Road • Columbia, MD 21045 • U.S.A. TEL (410) 290-6652 • FAX (410) 290-6654 http://www.pctestlab.com CERTIFICATE OF COMPLIANCE FCC Part 95 Certification Medtronic, Inc. Dates of Tests: Aug. 24 - Sept. 7, 2005 7000 Central Ave. Test Report S/N: 0509130630 Minneapolis, MN 55432-3576 Test Site: PCTEST Lab, MD U.S.A. Attention: Mr. Len Twetan, Senior Product Development Manager FCC ID LF5MICSW APPLICANT Medtronic, Inc. Classification: Licensed Non-Broadcast Transmitter Worn on the Body FCC Rule Part(s): §§§ 95 Procedure(s): EN 301 839-1 EUT Type: Medtronic Cure Link Monitor Trade Name(s): Medtronic Model(s): 2490C, 2490W Tx/Rx Frequency Range: 402.15 – 404.85 MHz Max. RF Output Power: 23.1 μW Frequency Tolerance: 100ppm Emission Designator: 135K0F1D Channel Capacity: 10 This equipment has been shown to be capable of compliance with the applicable technical standards as indicated in the measurement report and was tested in accordance with the measurement procedures specified in §2.947 and RSS-243. I attest to the accuracy of data. All measurements reported herein were performed by me or were made under my supervision and are correct to the best of my knowledge and belief. I assume full responsibility for the completeness of these measurements and vouch for the qualifications of all persons taking them. PCTEST certifies that no party to this application has been denied the FCC benefits pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. 862. Certification PCTEST PT. 95 REPORT FCC Certification Reviewed By: Quality Manager Test Report S/N: 0509130630 Test Dates: Aug. 24 - Sept. 7, 2005 EUT Type: Medtronic Cure Link Monitor FCC ID: LF5MICSW Page i of i TABLE OF CONTENTS ATTACHMENT A: COVER LETTER(S) ATTACHMENT B: ATTESTATION STATEMENT(S) ATTACHMENT C: TEST REPORT SCOPE 1 INTRODUCTION 2 INSERTS 3 DESCRIPTION OF TESTS 4-6 RADIATED MEASUREMENTS 7 FREQUENCY STABILITY 8-9 PLOTS OF EMISSIONS 10 LIST OF TEST EQUIPMENT 11 SAMPLE CALCULATIONS 12 CONCLUSION 13 ATTACHMENT D: TEST PLOTS ATTACHMENT E: FCC ID LABEL & LOCATION ATTACHMENT F: TEST SETUP PHOTOGRAPHS ATTACHMENT G: EUT PHOTOGRAPHS ATTACHMENT H: BLOCK DIAGRAM(S) ATTACHMENT I: SCHEMATIC DIAGRAM(S) ATTACHMENT J: USER’S MANUAL PCTEST PT. 95 REPORT FCC Certification Reviewed By: Quality Manager Test Report S/N: 0509130630 Test Dates: Aug. 24 - Sept. 7, 2005 EUT Type: Medtronic Cure Link Monitor FCC ID: LF5MICSW Page 1 of 13 MEASUREMENT REPORT 1.1 Scope Measurement and determination of electromagnetic emissions (EME) of radio frequency devices including intentional and/or unintentional radiators for compliance with the technical rules and regulations of the Federal Communications Commission. General Information Applicant Name: Medtronic, Inc. Address: 7000 Central Ave. Minneapolis, MN 55432-3576 Attention: Mr. Len Twetan, Senior Product Development Manager • FCC ID: LF5MICSW • Model(s): 2490C, 2490W • Quantity: Quantity production is planned • Tx/Rx Freq. Range: 402.15 – 404.85 MHz • Equipment Class: Licensed Non-Broadcast Transmitter Worn on the Body • Equipment Type: Medtronic Cure Link Monitor • Emission Designator: 46K0F1D • Modulation: FM • Frequency Tolerance: 100 ppm • Max. Power: 21.6 μW • FCC Rule Part(s): §§§§ 95 • Dates of Tests: Aug. 24 - Sept. 7, 2005 • Place of Tests: PCTEST Lab, Columbia, MD U.S.A. • Test Report S/N: 0509130630 PCTEST PT. 95 REPORT FCC Certification Reviewed By: Quality Manager Test Report S/N: 0509130630 Test Dates: Aug. 24 - Sept. 7, 2005 EUT Type: Medtronic Cure Link Monitor FCC ID: LF5MICSW Page 2 of 13 2.1 INTRODUCTION These measurement tests were conducted at PCTEST Engineering Laboratory, Inc. facility in New Concept Business Park, Guilford Industrial Park, Columbia, Maryland. The site address is 6660-B Dobbin Road, Columbia, MD 21045. The test site is one of the highest points in the Columbia area with an elevation of 390 feet above mean sea level. The site coordinates are 39° 11'15" N latitude and 76° 49'38" W longitude. The facility is 1.5 miles North of the FCC laboratory, and the ambient signal and ambient signal strength are approximately equal to those of the FCC laboratory. There are no FM or TV transmitters within 15 miles of the site. The detailed description of the measurement facility was found to be in compliance with the requirements of § 2.948 according to ANSI C63.4 on October 19, 1992. Measurement Procedure The radiated and spurious measurements were made outdoors at a 3-meter test range (see Figure2). The equipment under testing was placed on a wooden turntable, 3-meters from the receive antenna. The receive antenna height and turntable rotations was adjusted for the highest reading on the receive spectrum analyzer. A half-wave dipole was substituted in place of the EUT. This dipole antenna was driven by a signal generator and the level of the signal generator was adjusted to obtain the same receive spectrum analyzer reading. This level was recorded. For readings above 1 GHZ, the above procedure would be repeated using horn antennas and the difference between the gain of the horn and an isotropic antenna are taken into consideration. Figure 1. Map of the Greater Baltimore and Metropolitan Washington, D.C. area. Figure 2. 3-meter outdoor test site PCTEST PT. 95 REPORT FCC Certification Reviewed By: Quality Manager Test Report S/N: 0509130630 Test Dates: Aug. 24 - Sept. 7, 2005 EUT Type: Medtronic Cure Link Monitor FCC ID: LF5MICSW Page 3 of 13 3.1 INSERTS Block Diagram(s) & Circuit Diagram(s) The block diagram is shown in Attachment I, and the circuit diagram is shown in Attachment J. Operating Instructions The instruction manual is shown in Attachment K. PCTEST PT. 95 REPORT FCC Certification Reviewed By: Quality Manager Test Report S/N: 0509130630 Test Dates: Aug. 24 - Sept. 7, 2005 EUT Type: Medtronic Cure Link Monitor FCC ID: LF5MICSW Page 4 of 13 4.1 DESCRIPTION OF TESTS 4.2 Transmitter…
Text truncated - open the document above for the full version.
Effectivity Upon Approval Location/ Document # Revision Page 1 of 10 A Title 2490 COMPLIANCE TEST REPORT FOR ETSI EN 301 839-1 SECTION 10 Cardiac Rhythm Management MEDTRONIC CONFIDENTIAL This document is the property of Medtronic, Inc. and must be accounted for. Information herein is confidential. Do not reproduce it, reveal it to unauthorized persons or send it outside Medtronic without proper authorization. This document is under electronic document revision control. Printed or electronically distributed copies are considered uncontrolled. Author(s): Bill Verhoef Note: This document may be approved electronically through Documentum by the listed approvers. Role Name Signatures and Date Reviewed and Approved By: RF Engineer Bill Verhoef <Electronic Signature> Principal RF Technican Rod Wallace <Electronic Signature> 2490 System Engineer Don Diez <Electronic Signature> Change History Revision Description of Change A Initial Version Title Revision Page 2490 COMPLIANCE TEST REPORT FOR ETSI EN 301 839-1 SECTION 10 A 2 of 10 Cardiac Rhythm Management MEDTRONIC CONFIDENTIAL This document is electronically controlled. Printed copies are considered uncontrolled. MEDTRONIC CONFIDENTIAL 1.0 EXECUTIVE SUMMARY The intent of this testing is to collect data and compare the functionality of the 2490 to identified regulatory requirements as described in ETSI EN 301 839-1 Section 10. The 2490 successfully completed this protocol testing and met all requirements identified to the end that both the capabilities and limitations comply with the rules of this standard. 2.0 APPLICABLE REFERENCE DOCUMENTS 2.1 ETSI EN 301 839-1 SECTION 10 This document outlines the requirements governing the internationally allocated MICS frequency band. Section 10 within this document feed directly into the monitoring requirements tested in this document, to the end that both the capabilities and limitations comply with the rules of this standard. The version used was 1.1.1 dated June 2002. 2.2 2490 COMPLIANCE TEST PROCEDURE The 2490 Compliance Test Procedure is under document management control located in: documentum\Docbases\pulse\Patient Management Business\Project File: In- Progress\2490W\.........\2490 Compliance Test Procedure For ETSI EN 301 839-1 Section 10.doc Note: When the project is completed the path will change to: Project File: Final documentum\Docbases\pulse\Patient Management Business\Project File: Final\2490W\.........\2490 Compliance Test Procedure For ETSI EN 301 839-1 Section 10.doc 3.0 TESTS DESCRIPTION The tests performed verify system protocol operation compliance of the 2490 verses the identified regulatory requirements. The tests were performed using various test setups identified in the test procedure. Title Revision Page 2490 COMPLIANCE TEST REPORT FOR ETSI EN 301 839-1 SECTION 10 A 3 of 10 Cardiac Rhythm Management MEDTRONIC CONFIDENTIAL This document is electronically controlled. Printed copies are considered uncontrolled. MEDTRONIC CONFIDENTIAL 4.0 SUMMARY OF REQUIREMENTS VS RESULTS Requirement Limits Measured results ETSI EN 301 839-1 Section Number Requirement Description Units Min Max Min Max Test Result 10.1 Monitoring system threshold power level dBm ∞ -94 N/A -105.1 PASS 10.2 Monitoring system bandwidth KHz 200 ∞ 340 370 PASS 10.3.1.1 Monitoring system scan cycle time Sec 0 5 1.08 2.69 PASS 10.3.1.2 Monitoring system channel monitor period ms 10 ∞ Pass Pass PASS 10.4 Channel access related to threshold N/A 10.5 Discontinuation of session with a 5 s silent period Sec 0 5 0.662 0.791 PASS 10.6 Use of pre-scanned alternate channel N/A 5.0 TEST RESULTS 5.1 SECTION 10.1 MONITORING SYSTEM THRESHOLD POWER LEVEL 5.1.1 DATA Channel Number Monitor Sensitivity in dBm 2 -105.5 5 -105.1 9 -105.1 Title Revision Page 2490 COMPLIANCE TEST REPORT FOR ETSI EN 301 839-1 SECTION 10 A 4 of 10 Cardiac Rhythm Management MEDTRONIC CONFIDENTIAL This document is electronically controlled. Printed copies are considered uncontrolled. MEDTRONIC CONFIDENTIAL 5.2 SECTION 10.2 MONITORING SYSTEM BANDWIDTH 5.2.1 DATA Chan 2 @ 402.45MHz (20 dB BW = 160 + 210 = 370 KHz) PA+(__)KHz dBm PA -(__)KHz dBm 0 -96 0 -96 10 -96 -10 -96 20 -94 -20 -96 30 -93 -30 -97 40 -92 -40 -97 50 -92 -50 -97 60 -92 -60 -97 70 -92 -70 -96 80 -91 -80 -96 90 -90 -90 -95 100 -89 -100 -95 110 -88 -110 -95 120 -86 -120 -94 130 -85 -130 -93 140 -83 -140 -92 150 -81 -150 -90 160 -76 -160 -89 170 -170 -87 180 -180 -85 190 -190 -82 200 -200 -80 210 -210 -76 Title Revision Page 2490 COMPLIANCE TEST REPORT FOR ETSI EN 301 839-1 SECTION 10 A 5 of 10 Cardiac Rhythm Management MEDTRONIC CONFIDENTIAL This document is electronically controlled. Printed copies are considered uncontrolled. MEDTRONIC CONFIDENTIAL Channel 2 Bandwidth -100 -95 -90 -85 -80 -75 -70 -250-200-150-100-50050100150200 Frequency (KHz) Power (dBm) Chan 9 @ 404.55MHz (20 dB BW = 160 + 180 = 340 KHz) PA+(__)KHz dBm PA -(__)KHz dBm 0 -96 0 -96 10 -95 -10 -96 20 -95 -20 -96 30 -94 -30 -95 40 -94 -40 -95 50 -94 -50 -94 60 -94 -60 -94 70 -93 -70 -93 80 -93 -80 -93 90 -91 -90 -93 100 -91 -100 -93 110 -89 -110 -92 120 -88 -120 -90 130 -86 -130 -89 140 -85 -140 -88 150 -81 -150 -87 160 -77 -160 -85 170 -170 -82 Title Revision Page 2490 COMPLIANCE TEST REPORT FOR ETSI EN 301 839-1 SECTION 10 A 6 of 10 Cardiac Rhythm Management MEDTRONIC CONFIDENTIAL This document is electronically controlled. Printed copies are considered uncontrolled. MEDTRONIC CONFIDENTIAL 180 -180 -77 Channel 9 Bandwidth -100 -95 -90 -85 -80 -75 -70 -250-200-150-100-50050100150200 Frequency (KHz) Power (dBm) 5.3 SECTION 10.3.1.1 MONITORING SYSTEM SCAN CYCLE TIME 5.3.1 DATA Gated Channel 6 Gated Channel 6 Off Channel 2 Off Channel 3 Test # Tp1 (sec) Test # Tp1 (sec) 1 1.48 1 1.33 2 1.47 2 1.35 3 1.53 3 1.31 4 1.57 4 1.33 5 1.6 5 1.35 6 1.57 6 1.3 7 1.58 7 1.32 8 1.57 8 1.26 9 1.56 9 1.3 10 1.56 10 1.32 Title Revision Page 2490 COMPLIANCE TEST REPORT FOR ETSI EN 301 839-1 SECTION 10 A 7 of 10 Cardiac Rhythm Management MEDTRONIC CONFIDENT…
Text truncated - open the document above for the full version.
MEDTRONIC FCC ID: LF5MICSW EUT Photographs © 2005 PCTEST Lab. Medtronic Cure Link Monitor Model: 2490C MEDTRONIC FCC ID: LF5MICSW EUT Photographs © 2005 PCTEST Lab. Medtronic Cure Link Monitor Model: 2490C MEDTRONIC FCC ID: LF5MICSW EUT Photographs © 2005 PCTEST Lab. Medtronic Cure Link Monitor Model: 2490C
14085 Howard Rd · Dayton, Maryland · United States
| # | Rule Parts | Frequency Range | Power Output | Emission | Tolerance |
|---|---|---|---|---|---|
| 1 | 95I | 402 MHz - 405 MHz | 23.10 µW | 135KF1D | 100.0000000000 ppm |
Confirma DR/SR MRI SureScan, Effectra DR/SR MRI SureScan, Refina CSP DR/SR MRI SureScan, Restoria CSP DR/SR MRI SureScan, ReSyncra CSP DR MRI SureScan, HarmoniaBP DR MRI SureScan
Equipment Class
DTS - Digital Transmission System
MyCareLink Home Communicator Model 26950
Equipment Class
DTS - Digital Transmission System
MyCareLink Home Communicator Model 26900
Equipment Class
DTS - Digital Transmission System
Implantable Neurostimulator
Equipment Class
DCD - Part 15 Low Power Transmitter Below 1705 kHz
MCS3101CO
Equipment Class
DTS - Digital Transmission System